Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study to Evaluate the Safety of a Complex Gut Bacterial Consortium (MITI 001) for the Treatment of Irritable Bowel Syndrome With Diarrhea

NCT07238790 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT07238790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07238790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study to Evaluate the Safety of a Complex Gut Bacterial Consortium (MITI 001) for the Treatment of Irritable Bowel Syndrome With Diarrhea
Lead sponsor
Stanford University
Phase
Phase 1
Overall status
Not yet recruiting
Start date
December 31, 2025
Completion date
December 31, 2030
Enrollment
13 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea, ibs (irritable bowel syndrome)